Becton Dickinson Unit Headed to Trial in Catheter Antitrust Case

Becton Dickinson & Co. subsidiary C.R. Bard Inc. must face trial on claims that it’s trying to corner the market for certain blood vessel catheters by leveraging its monopoly on an electronic system for locating them within the body, a federal judge in Syracuse, N.Y., ruled.

Judge Brenda K. Sannes denied dueling motions by Bard and AngioDynamics Inc., the rival device maker leading the lawsuit, refusing either to throw out the antitrust case or impose liability without the benefit of a trial in the U.S. District Court for the Northern District of New York.

Because “both parties take positions that ...